Zhejiang Tailin BioEngineering Co.,Ltd

Equities

300813

CNE100003S89

Advanced Medical Equipment & Technology

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-14 pm EDT			5-day change	1st Jan Change
21.99 ^CNY	-8.15%		+17.97%	-10.32%

Apr. 24	Zhejiang Tailin BioEngineering Co.,Ltd Proposes Final Cash Dividend for 2023	CI
Apr. 23	Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Zhejiang Tailin Bioengineering Co.,Ltd Approves the Final Cash Dividend for the Year 2021, Payable on May 18, 2022

May 10, 2022 at 03:33 pm EDT

Zhejiang Tailin BioEngineering Co.,Ltd announced that Annual General Meeting of 2021 on 09 May 2022, approved the final Cash dividend/10 shares (tax included) of CNY 3.00000000 for the year 2021, with record date as 17 May 2022, payable date as 18 May 2022, ex-date as May 18, 2022.

Latest news about Zhejiang Tailin BioEngineering Co.,Ltd

Zhejiang Tailin BioEngineering Co.,Ltd Proposes Final Cash Dividend for 2023	Apr. 23	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 23	CI
Zhejiang Tailin Medical Engineering Co., Ltd. announced that it expects to receive CNY 170 million in funding from Zhejiang Tailin BioEngineering Co.,Ltd	Dec. 11	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Zhejiang Tailin Bioengineering Co.,Ltd Approves Cash Dividend for the Year 2022, Payable on 11 May 2023	23-04-27	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Zhejiang Tailin Bioengineering Co.,Ltd. Proposes Final Cash Dividend for 2022	23-04-03	CI
Certain A Shares of Zhejiang Tailin BioEngineering Co.,Ltd are subject to a Lock-Up Agreement Ending on 15-JAN-2023.	23-01-14	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-28	CI
Zhejiang Tailin Medical Engineering Co., Ltd. announced that it has received CNY 40 million in funding from Zhejiang Tailin BioEngineering Co.,Ltd	22-06-08	CI
Zhejiang Tailin Bioengineering Co.,Ltd Approves the Final Cash Dividend for the Year 2021, Payable on May 18, 2022	22-05-10	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
Zhejiang Tailin BioEngineering Co.,Ltd Proposes Final Cash Dividend for the Year of 2021	22-04-19	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-18	CI
Zhejiang Tailin Life Science Co., Ltd. announced that it expects to receive CNY 40 million in funding from Zhejiang Tailin BioEngineering Co.,Ltd	22-04-17	CI
Zhejiang Tailin Bioengineering Sells $33 Million RMB Convertible Bonds	21-12-28	MT
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Zhejiang Tailin Bioengineering Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-29	CI
Zhejiang Tailin Bioengineering Co.,Ltd Approves Cash Dividend for the Year 2020, Payable on May 26 , 2021	21-05-18	CI
Zhejiang Tailin BioEngineering Co.,Ltd Proposes Final Dividend for 2020	21-04-26	CI
Zhejiang Tailin Bioengineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-25	CI
Zhejiang Tailin Bioengineering Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-25	CI
Zhejiang Tailin Bioengineering Co.,Ltd Announces Management Appointments	21-04-23	CI

Chart Zhejiang Tailin BioEngineering Co.,Ltd

Duration

Period

Chart Zhejiang Tailin BioEngineering Co.,Ltd

More charts

Company Profile

Zhejiang Tailin Bioengineering Co., Ltd. is a China-based company mainly engaged in pharmaceutical equipment business. The Company's main business is the research, development, manufacturing and sales of microbial detection and control technology system products, organic substance analysis instruments and other pharmaceutical equipment. Specific products include various consumables, instruments and equipment, which can be used alone or in combination for the production and quality of sterile drugs. The application areas that can be expanded include medical and health, food safety, disease prevention and control, biosecurity, inspection and quarantine, biological engineering, laboratory animals, and environmental protection. The Company distributes its products within domestic market and to overseas markets.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-25 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
ZHEJIANG TAILIN BIOENGINEERING CO.,LTD	-10.32%	360M
THERMO FISHER SCIENTIFIC	+13.21%	227B
DANAHER CORPORATION	+13.95%	192B
INTUITIVE SURGICAL, INC.	+17.71%	136B
BOSTON SCIENTIFIC CORPORATION	+28.52%	108B
SIEMENS HEALTHINEERS AG	+1.67%	64.07B
EDWARDS LIFESCIENCES CORPORATION	+17.62%	52.1B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+7.04%	51.87B
AGILENT TECHNOLOGIES, INC.	+10.74%	44.33B
GE HEALTHCARE TECHNOLOGIES INC.	+5.41%	36.75B

Other Advanced Medical Equipment & Technology